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Abstract
Dopamine (DA) and other neurotransmitters affect nonneuronal tissues in
insects by circulating in the hemolymph. In several organisms, DA has been
shown to modulate distinct aspects of cardiac function but the signal trans-
duction pathways that mediate dopaminergic effects on the heart are not well
characterized. Here, we used a semiintact Drosophila melanogaster larva prepa-
ration and drugs targeting DA receptors and canonical second messenger
pathways to identify signaling cascades that mediate the effect of DA on a
myogenic heart. DA has a positive chronotropic effect that is mimicked by
SKF38393 (type-1 DA receptor agonist) and quinpirole (type-2 DA receptor
agonist). SCH23390 and spiperone (type-1 and type-2 DA receptor antago-
nists) are moderately effective at inhibiting DA’s effect. An adenylate cyclase
inhibitor (SQ,22536) is also effective at blocking the stimulatory effect of DA
but the drug has its own dose-dependent effect. Activation of protein kinase
C with a diacylglycerol analog has a stimulatory effect on heart rate (HR).
These results suggest that (1) both DA receptor subtypes are expressed in
third instar larva cardiac myocytes to increase HR in response to rising levels
of DA in the hemolymph, and (2) canonical second messenger pathways mod-
ulate HR in D. melanogaster larvae. Having these disparate signaling cascades
converge toward a common modulatory function appears redundant, but in
the context of multiple cardioactive chemicals this redundancy is likely to
increase the fidelity of signal transduction.
Introduction
Dopamine (DA) is a well characterized neurotransmitter
that also exhibits modulatory effects on peripheral tissues.
Cardiac function is influenced by DA in several species,
for example, Periplaneta americana (Collins and Miller
1977), Ligia exotica (Yamagishi et al. 2004b), Tapes
watlingi (de Rome et al. 1980), Drosophila melanogaster
(Zornik et al. 1999), Canus lupus (Chen et al. 2007),
Cavia porcellus (Habuchi et al. 1997), Mus musculus
(Asghar et al. 2011), and Homo sapiens (Cosyns et al.
2013). Chronic use of DA prodrugs (e.g., L-dopa) has
been linked to cardiac valve dysfunction in man (Delgado
et al. 2012). Though DA receptors have been identified in
mammalian cardiac tissue (Cavallotti et al. 2010;
Tonnarini et al. 2011), pharmacological analysis of the
effects of DA on heart rate (HR) and other aspects of car-
diac function are lacking. Doing so will increase our
understanding of how the cardiac rhythm is modulated
and how it is affected by systemic DA homeostasis.
The larval D. melanogaster heart is a myogenic tube that
spans the rostral:caudal axis of the animal (Gu and Singh
1995). Hemolymph is drawn into the heart through ostia in
the posterior pump (which is analogous to a ventricle) and
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circulated through an aorta back into the visceral lumen.
Similarities in the developmental genetics (Bodmer 1995;
Bodmer and Venkatesh 1998) and physiology (Choma
et al. 2011) between D. melanogaster and human hearts
make the larval heart an insightful model system.
DA has a positive chronotropic effect (meaning change
in HR) on the adult and pupal heart (Johnson et al.
1997; Zornik et al. 1999). To investigate the molecular
mechanisms mediating cardiac dopaminergic effects, we
used the semi-intact Drosophila larva preparation (Cooper
et al. 2009). One advantage of this preparation for phar-
macological analysis is that the heart is quickly isolated
from the nervous system and other sources of modulatory
input. Because DA homeostasis is often manipulated sys-
temically to study larval behavior (Neckameyer and Bhatt
2012) we are also interested in the effects of DA on car-
diac function.
In the nervous system, and in smooth muscle, dopami-
nergic modulation proceeds through canonical G protein
coupled receptor (GPCR) pathways (Neve et al. 2004).
Arthropod DA receptors exhibit strong functional and
pharmacological similarities to vertebrate receptors
(Mustard et al. 2005; Yuan and Lee 2007). Four DA
receptors have been described in D. melanogaster. Based
on sequence identity and cAMP accumulation assays they
can be classified as type-1 (DopR, DopR2, DopEcR) or
type-2 (D2R) (Gotzes et al. 1994; Sugamori et al. 1995;
Gotzes and Baumann 1996; Han et al. 1996). Type-1 DA
and type-2 DA receptors are either positively or negatively
coupled to adenylate cyclase through stimulatory and
inhibitory G protein alpha subunits. Type-2 DA receptors
are also known to function through protein kinase C
(PKC) and calcium-dependent pathways (Yan et al.
1999). The degree to which GPCRs activate phospholi-
pase-C and other second messenger cascades in D. mela-
nogaster hearts is not completely understood and we are
far from understanding how information from multiple
signaling pathways is integrated. The aim of this study
was to determine if vertebrate drugs targeting DA recep-
tors and second messengers have an effect on this prepa-
ration with the long-term goal of dissecting interactions
between multiple pathways.
Materials and Methods
HR assay
A Canton S. strain that has been isogenic in the lab for
several years was used for all experiments. Flies were
maintained on a 12 h light:dark cycle in bottles at med-
ium density and fed standard cornmeal fly food (Bloom-
ington stock center recipe). Early third instar larvae were
pinned ventral side up on a glass plate and dissected in a
droplet of HL3 saline (Stewart et al. 1994): (in mmol/L)
70 NaCl, 5 KCl, 20 MgCl2, 10 NaHCO3, 1 CaCl2, 5
trehalose, 115 sucrose, 25 N,N-Bis-(2-hydroxyethyl)-2-
aminoethane sulfonic acid (BES). Note the following
modifications: pH was decreased from 7.2 to 7.1 and BES
buffer was increased from 5.0 mmol/L to 25.0 mmol/L to
maintain stable pH. All recordings were made at room
temperature (21–23°C) between 9 and 5 PM.
The larva dissection was first described by Gu and
Singh (1995). Early third instars were opened by an inci-
sion in the ventral midline and visceral organs were
removed without touching the heart. After recovering
from surgery for 5 min the heart was visualized through
a dissecting microscope and the baseline HR was mea-
sured by directly counting contractions in the posterior
“heart” region. The saline was then carefully removed and
exchanged with the various drug solutions. Counts in the
new solution were taken 1 min after the exchange to
allow the heart time to adjust after mechanical agitation,
and for the ninth minute after applying the solution to
determine the duration of modulatory effects. Hearts that
did not beat continuously or stopped beating at the end
of the experiment were not included in our analyses. As a
control for the solution change, HR was measured after
exchanging saline with fresh saline.
Pharmacology
SCH23390, SKF38393, Quinpirole, SQ22536, and phor-
bol-12-myristate-13-acetate (PMA) were purchased from
Sigma Aldrich (St. Louis, MO). Spiperone was purchased
from TOCRIS (Minneapolis, MN). DA HCl and each of
the saline salts were purchased from Sigma. DA was
weighed out and prepared daily. The other drugs were
prepared from stock solutions. Lipophilic drugs were dis-
solved in saline solutions containing less than 1.0%
dimethyl sulfoxide (DMSO). Saline containing 1.0%
DMSO did not have an effect on larval HR.
Analysis
Heart rates were determined by counting the number of
contractions observed in the posterior region of the heart
(between seventh and eight abdominal segments). Con-
tractions were counted by visual inspection through a dis-
section microscope. The rates measured after drug
treatment were normalized to the rate measured before
drug treatment (baseline). Normalized values were then
pooled for each treatment and the two-tailed Student’s
t-test (Sigma Plot, 12.0) was used to compare drug treat-
ments to saline treatments (control) and to compare
different concentrations of drug treatments. Data points
depict the mean and SEM for each treatment at a given
2013 | Vol. 1 | Iss. 2 | e00020
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1-min interval during the experiment. Sample sizes for
each experiment are indicated in the figure legends.
Results
DA increases larval HR
The average baseline HR measured in dissected third instar
larvae was 98.9  2.5 beats per minute (N = 164). The
distribution of baseline HRs in this preparation was skewed
toward lower frequencies and the range exhibited threefold
variation (Fig. 1A). Surgical and environmental differences
explain a portion of this variation. Previous reports in
nondissected flies show that up to 25% of the variation can
be attributed to genotypic differences (Robbins et al.
1999). Statistical analyses were performed on baseline-
normalized values to account for this variation.
On average 0.1 lmol/L DA increased HRs 36.02% 
7.15% above baseline (Fig. 1). At this concentration HR
increased in each individual experiment (Fig. 1B). DA
caused a rapid rise in HR upon exposure and maintained
a heightened level during the 0.1 lmol/L treatment
(Fig. 1C). In most cases the increase persisted for at least
10 min and was not immediately washed out by saline
after the treatment. The dose–response results (Fig. 1D)
would suggest that 0.1 lmol/L DA reaches a saturation
effect in increasing HR as higher concentrations did not
produce significantly higher rates.
Type 1 and 2 DA receptors mediate
dopaminergic modulation of larva HR
Pharmacological approaches were used to investigate the
mechanisms of dopaminergic modulation in this system.
Synthetic vertebrate DA receptor agonists and antagonists
are known to bind to Drosophila DA receptors and have
pharmacological effects comparable to vertebrates in
heterologous expression systems (Gotzes et al. 1994). In
Figure 1. Dopamine (DA) has a positive chronotropic effect on larval heart rate (HR). (A) Baseline HR counts from all experiments, that is,
5 min after dissection and prior to application of drugs. (B) HR counts from seven individual experiments, before and 2 min after the saline was
exchanged with 0.1 lmol/L DA. (C) Mean HR (normalized to baseline) plotted with time to show the full time course of the experiments
(n = 7; **P = 0.005 and *P = 0.03 compared to saline changes, Student’s t-test). The red bar depicts how long preparations were incubated in
the drug solution. (D) Mean HR counts from the second and ninth minute of the experiment in response to different DA concentrations (n > 7
for each concentration; *P < 0.05 at 2nd minute, +P < 0.05 for the 9th minute compared to saline changes at those times, Student’s t-test).
ª 2013 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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Drosophila cell culture (Yuan and Lee 2007) and in the
intact nervous system (Yellman et al. 1997) several com-
mon vertebrate DA receptor drugs have been used to cor-
relate specific DA receptors with a modulatory effect. The
type-1 and type-2 DA receptor agonists used in these
experiments were SKF38393 and quinpirole. SKF38393
was applied to larval hearts at 0.01, 0.1, and 10.0 lmol/L
concentrations. At each concentration there was an initial
dose-dependent increase (20–70%) in HR followed by a
return to rates that were 1–36% above baseline (Fig. 2A).
The type-2 agonist quinpirole caused an initial
dose-dependent increase in HR that grew during the
incubation to 12–53% above baseline (Fig. 2B). This was
in contrast to the chronotropic effect of SKF38393, which
diminished during the course of treatment (P = 0.03 at
10 lmol/L). Also the acute chronotropic effect of
SKF38393 was smaller at higher concentrations. These
results suggest that the type-1 DA receptors desensitize in
response to prolonged exposure to ligand. Mechanisms of
DA receptor desensitization have been described in neu-
ronal tissues (Rex et al. 2008; Beaulieu and Gainetdinov
2011) but further pharmacological characterization is
needed to confirm this phenomenon in D. melanogaster
cardiac cells.
Antagonists for both DA receptor subtypes were mod-
erately effective at blocking the effect of DA. For those
experiments the dissected preparation was pretreated with
either antagonist before adding a solution containing DA
and the antagonist. HRs for the DA treatment were nor-
malized to values recorded at the end of the pretreatment.
The effect of DA (10 lmol/L) on HR was completely
inhibited by antagonists for either DA receptor 9 min
after DA was applied (Fig. 3A). The type-1 DA receptor
antagonist (SCH23390, 10 lmol/L) significantly blocked
the immediate effect of DA but the type-2 antagonist
(spiperone, 10 lmol/L) was not as effective at this time
point (i.e., 2 min after DA was applied). Spiperone ini-
tially increased HR during pretreatment but the rate
returned to baseline levels before DA was added (Fig. 3B).
Figure 2. Synthetic vertebrate agonists for the two dopamine (DA)
receptors increase HR in 3rd instar larvae. Agonist application
regimens and HR counts were identical to DA experiments in
Figure 1C, that is, change is shown relative to baseline 2 and 9 min
after the drugs were applied. (A) SKF38393 (type-1 DA receptor
agonist) and (B) quinpirole (type-2 DA receptor agonist) have
positive chronotropic effects (**P < 0.005, *P < 0.05 compared to
2nd minute of saline treatment, Student’s t-test, +P < 0.05
compared to 9th minute of saline treatment, Student’s t-test; N > 5
different individuals for each treatment). The magnitude of the
effects is statistically similar to DA but there are subtle differences
in temporal and dose response. Efficacy of the type-1 DA receptor
agonist decreased at higher concentrations.
Figure 3. Type-1 and type-2 DAR antagonists partially block the
modulatory effect of dopamine (DA) on larval HR. Dissected larva
hearts were pretreated with a DA receptor antagonist for 10 min
prior to DA application. The dopaminergic increase in HR was
partially blocked by either drug 2 min after DA application, and
almost completely blocked 9 min after DA application (*P < 0.05
compared to the effect of DA without the antagonist at that time
point, Student’s t-test, n > 8 different individuals for each
treatment). SCH23390 is a type-1 DA receptor antagonist (gray
data points) and spiperone is a type-2 DA receptor antagonist
(black data points). The dopaminergic effect without pretreatment
with antagonists is shown in light red. (B) SCH23390 alone did not
have an effect on HR at either time point. Spiperone caused a
slight but significant increase in HR that diminished before DA was
added.
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Possible explanations for this result are that the drug has
off-target effects or that the drug inhibited the function
of a constitutively active DA receptor. Constitutively
active DA receptors have been identified in Aplysia heart
(Barbas et al. 2006) and in mammalian nervous system
(Tiberi and Caron 1994; Charpentier et al. 1996).
Adenylate cyclase and PKC are involved in
modulation of HR
To determine if DA acts on the heart through classical
stimulatory GPCR pathways, the vertebrate adenylate
cyclase inhibitor SQ22536 (SQ) was tested in the same
manner as the DA receptor antagonists, that is, the drug
was applied for 10 min before applying it in solution with
10 lmol/L DA. HRs were measured at the end of this
treatment and later time points were normalized to those
pretreatment rates. Under these conditions the modula-
tory effect of DA (10 lmol/L) was significantly inhibited
by 5 lmol/L SQ (Fig. 4A). Oddly SQ was less effective at
500 lmol/L and at both concentrations SQ alone had a
stimulatory effect on HR (Fig. 4B). Though the drug
clearly inhibits dopaminergic modulation in this context,
we are unable to rule out the possibility of off-target
mechanisms.
The diacylglycerol (DAG) analog PMA was used to
determine if PKC is involved in modulation of larval HR.
This drug consistently increased HR and was more effec-
tive at 100 lmol/L than at 10 lmol/L (Fig. 5). At both
concentrations the effect lasted for 10 min and was not
immediately washed out.
Calcium ion reduction inhibits dopaminergic
modulation of larval HR
To test the hypothesis that Ca2+ influx is a factor in
dopaminergic modulation of larval HR, we experimented
with various levels of [Ca2+]o. The normal HL3 saline
contains 1.0 mm CaCl2 (Stewart et al. 1994). At 0.1 mm
Ca2+ the hearts did not beat, but changing the saline to
0.5 mm Ca2+ revived them from cardiac arrest (n = 5).
In this low calcium solution DA (10 lmol/L) did not
have an effect on HR (Fig. 6). High calcium saline
(2.0 mm) did not change the effect of DA at any point.
Therefore, calcium influx is necessary for dopaminergic
modulation of HR and it appears that [Ca2+]o contributes
its maximum input at 1 mmol/L. Higher [Ca2+]o is
known to substantially increase HR and further modula-
tory effects are difficult to ascertain at higher frequencies
(Desai-Shah et al. 2010). After washing away DA in the
low calcium solution there was a 40% increase in HR.
Slight increases after washout were observed in other
treatments (Figs. 1C and 3) but this phenomenon was
accentuated in this condition. One explanation is that
after several minutes without calcium the tissue developed
an increased sensitivity to mechanical stress, causing an
elevated response to the solution change.
Figure 4. Dopaminergic modulation of larval HR is mediated by
adenylate cyclase. Dissected hearts were pretreated for 10 min with
SQ22536 (adenylate cyclase inhibitor) as in Figure 3. HRs shown
here were normalized to the rate recorded at the end of SQ22536
treatment. (A) At 500 lmol/L (black data points) and at 5 lmol/L
(gray data points) the drug attenuated the effect of dopamine
(DA). Inhibition was only statistically significant for the lower
concentration (*P < 0.05 compared to DA alone (shown in light
red), Student’s t-test: n > 9 individuals for each concentration).
(B) At both concentrations SQ22536 alone increased HR relative to
saline treatment (*P < 0.05, Student’s t-test, pretreatment rates
from preparations in [A]).
Figure 5. Activation of protein kinase C (PKC) has a positive
chronotropic effect on HR. Phorbol-myristate-acetate (PMA), a cell
permeable diacylglycerol analog, was used to determine if PKC acts
as a second messenger in modulation of insect HR. The stimulatory
effect of PMA was much stronger at the higher concentration
(*P < 0.005 after 2nd minute compared to 10 lmol/L, +P < 0.005
after the 9th minute compared to 10 lmol/L; n > 10 different
animals for both concentrations).
ª 2013 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2013 | Vol. 1 | Iss. 2 | e00020
Page 5
J. S. Titlow et al. Dopamine Pharmacology in Drosophila Hearts
Discussion
Positive chronotropic effect of DA on D.
melanogaster larval hearts
Endogenous DA levels fluctuate in response to environ-
mental cues and an animal’s state of arousal (Noguchi
et al. 1995). In insects DA modulates peripheral organs
by circulating in hemolymph at concentrations in the
micromolar range (Matsumoto et al. 2003). The source of
hemolymph DA is debatable but it likely originates from
hypodermal cells that secrete DA to harden the cuticle
(Wright 1987; Friggi-Grelin et al. 2003) or from neurohe-
mal axon terminals (Buma 1988) and varicose projections
within the nervous system (Helle et al. 1995), as is the
case in other invertebrates. Regardless of the source, our
data show how a sudden increase in DA has a positive
chronotropic effect on the semi-intact larval heart in
D. melanogaster. This effect has not been described in lar-
vae but Zornik et al. (1999) reported a positive chrono-
tropic effect in adults and a negative effect in pupae. Two
factors that may have led to different findings between
the two studies were the developmental stage and geno-
type. Here, early third instar larvae from the Canton S
line were used whereas the previous study used Oregon R
flies in the “wandering” third instar stage. Using intact P1
pupal stage from the Canton S line, Johnson et al. (1997)
observed that DA has a positive chronotropic effect. Simi-
lar developmentally specific dopaminergic effects on HR
have also been reported in the sea roach, L. exotica
(Yamagishi et al. 2004a). Moreover DA has a positive
chronotropic effect on the cockroach heart (Collins and
Miller 1977). The data suggest that DA is regulating HR
by modulating pacemaker activity in cardiac myocytes
(Johnson et al. 2002), but whether modulation occurs
directly in the myocardial cell layer or indirectly through
the epicardium is unclear (Su et al. 1999). We did not
measure contractile force generated by the cardiac tube
but experiments in Limulus polyphemous have shown that
DA can have a positive ionotropic effect (change in
contractile function) on invertebrate heart muscle and
that the effect is mediated by cyclic-AMP and PKC
(Groome and Watson 1989).
Canonical second messenger pathways
involved in fruit fly HR modulation
Using SQ and ion substitution we showed that DA exerts
its positive chronotropic effect on HR through adenylate
cyclase and calcium influx (Figs. 4 and 6). Coupling of a
D. melanogaster type-1 DA receptor to increases in intra-
cellular Ca2+ and cyclic-AMP through G proteins has
been demonstrated in Xenopus oocytes (Reale et al. 1997).
The effect of cyclic-AMP is subtle and confounded by the
fact that SQ increased HR. In pupal hearts a cyclic-AMP
analog (8-bromo-cAMP) had a very small stimulatory
effect (9.5%) and forskolin did not significantly affect HR
(Johnson et al. 2002). Mutations in adenylate cyclase
(rutabaga) and cAMP phosphodiesterase (dunce) did not
significantly alter the stimulatory effects of cardioactive
molecules (Johnson et al. 2002). However, there is strong
genetic evidence that indicates the involvement of calcium
and phospholipase C in modulation of HR (Johnson
et al. 2002) and our pharmacological data are consistent
with those findings.
We showed that direct activation of PKC has a dose-
dependent stimulatory effect on larval HR (Fig. 5). The
PKC pathway could modulate HR by targeting calcium
channels. In rat ventricular myocytes an L-type calcium
current is modulated through a PKC-dependent pathway
(Chen et al. 2012). Calcium handling in Drosophila myo-
cytes exhibits many of the same physiological properties
observed in mammalian myocytes. L-type Ca2+ channels
enable periodic waves of calcium influx (Gu and Singh
1995). Intracellular calcium is in turn buffered by sarco-
plasmic/endoplasmic reticulum Ca2 + -ATPase (Sanyal
et al. 2006) and a sodium/calcium exchanger (Desai-Shah
et al. 2010). Larval HR is positively correlated with extra-
cellular calcium, for example, decreasing [Ca2+]o from
1.0 mmol/L to 0.5 mM decreases HR by over 50%, and
increasing [Ca2+]o from 1.0 to 2.0 mmol/L increases HR
by 40% (Desai-Shah et al. 2010). Although the experi-
ments reported here did not directly address activation of
PKC signaling by DA, evidence from rat myocytes
Figure 6. The modulatory effect of dopamine (DA) on heart rate
(HR) is correlated with extracellular Ca2+ levels. 1.0 mmol/L (red
data points) is the normal [Ca2+] used for HL3 (hemolymph-like) fly
saline. In low [Ca2+] conditions (gray data points) the positive
chronotropic effect of DA was not observed. In high calcium (black
data points) the effect of DA is unaffected, though the persistence
of the dopaminergic effect is slightly stronger in this condition.
Data points with different letters exhibited significantly different
rates (P < 0.05, Student’s t-test; n > 6 for each [Ca2+] tested). The
solution used for dissection contained the same [Ca2+] as the
treatment solution.
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(Li et al. 2009) and Aplysia sensory neurons (Dunn et al.
2012) indicate that DA modulates the function of those
cells through a PKC-dependent pathway.
Though DA and the DA receptor agonists used here
were effective at doses that are likely below the threshold
to exert off-target effects, our experiments do not com-
pletely rule out the possibility that DA was acting through
an adrenergic or other aminergic receptor. Norepineph-
rine and an alpha-adrenergic receptor agonist have been
shown to increase pupal HR in D. melanogaster (Johnson
et al. 2002). However, there are no true adrenergic recep-
tors in D. melanogaster (Evans and Maqueira 2005). These
molecules are believed to act through octopamine or tyra-
mine receptors, which exhibit pharmacological properties
similar to adrenergic receptors (Bayliss et al. 2013).
Future studies and impact
In D. melanogaster a leak current from an outward recti-
fying potassium channel (ORK1) regulates HR by control-
ling membrane excitability and in turn the slow diastolic
depolarization phase (Lalevee et al. 2006). It is possible
that DA influences HR through protein kinases that inac-
tivate ORK1 through phosphorylation. Indeed it was
shown that HR increased when expression of this channel
was knocked down (Lalevee et al. 2006). The current
work establishes a system for addressing hypotheses about
the mechanisms of aminergic modulation of the heart
using electrophysiological techniques and transgenic flies.
In mammals the effects of DA on cardiovascular func-
tion have been studied extensively. Chronotropic, iono-
tropic, and pressor effects have been demonstrated in
guinea pigs, rabbits, dogs, and in humans (Tsai et al.
1967; Wakita 2007). In several instances the results are
contradictory and complicated by the fact that DA acts
on smooth muscle as a vasodilator, it modulates parasym-
pathetic innervations to the heart, and can be taken up
by neurons and converted to norepinephrine. Nonetheless
it has been shown that each DA receptor subtype is
expressed in mammalian hearts (Cavallotti et al. 2010;
Tonnarini et al. 2011), giving some support to the idea
that DA or DA receptor agonists could modulate the
mammalian heart directly. A current concern is that
extended use of DA prodrugs (e.g., L-dopa) and DA
receptor agonists for neurobiological disorders has been
associated with cardiac valve dysfunction (Delgado et al.
2012; Trifiro et al. 2012). Though circulating DA levels
are typically not high enough to activate DA receptors
(Zeng and Jose 2011), these pharmacological agents seem
to influence cardiac function through DA pathways. The
larval heart has a pair of intracardiac cells that function
as a valve (Zeitouni et al. 2007; Lehmacher et al. 2012),
so this system could potentially be used to address the
molecular mechanisms that cause this valvular dysfunc-
tion associated with DA treatments.
Conclusion
Our pharmacological analysis indicates that the chrono-
tropic effect of DA is mediated by functionally conserved
G protein coupled DA receptors and canonical second
messenger pathways. The results also indicate that
calcium flux is an important element of dopaminergic
modulation in the heart. These data can guide future
studies that address interactions between signaling path-
ways and homeostatic changes to monoamine signaling
using the genetic tools available in this system.
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